Merck & Co., Inc.



2006 Annual Review

Corporate Information

  • Annual Meeting

    • The Annual Meeting of Stockholders will be held at 2 p.m., ET, on Tuesday, April 24, 2007, at the Edward Nash Theatre at
      Raritan Valley Community College, Route 28 and Lamington Road, North Branch, NJ.
  • Stock Trading Information

    • Merck stock is listed on the New York Stock Exchange (ticker symbol: MRK), the Philadelphia Stock Exchange and the Paris Stock Exchange.
      • Direct Purchase of Merck Stock and Dividend Reinvestment Plan

        • You can purchase shares directly from the Company through the Merck Stock Investment Plan. Shares also may be purchased by automatic investment each month. Merck’s Dividend Reinvestment Plan allows dividends (all or part) to be automatically reinvested to purchase additional Merck shares. Call 800-522-9114, or write to:

          Merck Stockholder Services WS3AB-40
          Merck & Co., Inc.
          One Merck Drive, P.O. Box 100
          Whitehouse Station, NJ 08889-0100.
      • Stockholder Services

        • Call Monday through Friday, 8 a.m. to 8 p.m., ET, with questions on stock-related matters, including verification of your holdings, to change your address or to report lost or missing dividends. Call 800-522-9114, or write to Merck Stockholder Services at the address listed above.
      • For Changes or Lost Stock Certificates

        • If you want to transfer your stock, change ownership or if you have lost your stock certificates, call 800-522-9114, or write to:
          Merck Shareowner Services
          Wells Fargo Bank, N.A.
          161 N. Concord Exchange
          South St. Paul, MN 55075-1139.
  • Independent Registered Public Accounting Firm

    • PricewaterhouseCoopers LLP
      400 Campus Drive
      Florham Park, NJ 07932
      973-236-4000
  • News and Information

    • News on Call

      • Access Merck news 24 hours a day, seven days a week by calling 800-CALL-MRK (800-225-5675).
    • Investor Relations

      • Securities analysts and investment professionals with business-related questions should call Investor Relations at 908-423-5881.
    • Media Relations

    • Corporate Documents

      • Visit www.merck.com or write to:
        Merck Public Affairs
        WS1A-40
        Merck & Co., Inc.
        One Merck Drive, P.O. Box 100
        Whitehouse Station, NJ 08889-0100
        for copies of:
        • Merck’s 2006 Form 10-K, as filed with the Securities and Exchange Commission.

        • Report on Diversity at Merck.
        • Policies of the Board (Merck governance principles).
        • Merck Board Committee Charters — Audit, Compensation and Benefits, Corporate Governance, Executive, Finance, Public Policy and Social Responsibility, and Research.
        • Merck’s Code of Conduct — Our Values and Standards.
  • Forward-Looking Statements

    • This report contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. The forward-looking statements may include statements regarding product development, product potential or financial performance. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this report should be evaluated together with the many uncertainties that affect Merck's business, particularly those mentioned in the cautionary statements in Item 1 of Merck's Form 10-K for the year ended Dec. 31, 2006, and in its periodic reports on Form 10-Q and Form 8-K, which the Company incorporates by reference.
  • Trademarks

    • All product or service marks appearing in type form different from that of the surrounding text are trademarks or service marks owned by or licensed to Merck & Co., Inc., its subsidiaries or affiliates. Cozaar and Hyzaar are registered trademarks of E.I. du Pont de Nemours and Company, Wilmington, Delaware, USA. Zetia and Vytorin are trademarks owned by an entity of the Merck/Schering-Plough Pharmaceuticals partnership.
  • Patient Assistance Programs

    • Merck offers several programs to give individuals greater access to the medicines and vaccines they need. For more information, visit www.merckhelps.com.
  • Corporate Responsibility at Merck

    • Merck’s 2004-05 Corporate Responsibility Report is available online. More information about corporate responsibility at Merck is available at www.merck.com/cr.
  • Images of Mixed Sources and Green-e


 Copyright © 2009 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.  Privacy  Terms of Use  Sitemap